AGC Inc. announced that following the approval at the meeting of the Board of Directors held on June 12, 2024, the company announced the following change in the assignments of Executive Officers. Patricio Massera resigned as Executive Officer, AGC Biologics CEO, Life Science Company with effect from June 30, 2024. The company appointed Tadashi Murano as Senior Executive Officer, President of Life Science Company AGC Biologics CEO from Senior Executive Officer, President of Life Science Company with effect from July 1, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5,206 JPY | -0.19% |
|
-1.14% | -0.57% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.57% | 6.87B | |
+3.20% | 31.4B | |
+29.70% | 19.24B | |
-17.09% | 16.89B | |
-0.46% | 14.71B | |
-14.71% | 8.12B | |
-10.47% | 8.06B | |
-14.88% | 7.1B | |
+26.97% | 6.9B | |
+10.14% | 6.13B |
- Stock Market
- Equities
- 5201 Stock
- News AGC Inc.
- AGC Inc. Announces Executive Changes